title: [Miliary tuberculosis following treatment with adalimumab].
authors.forename: U
authors.initials: U
authors.lastname: Lertxundi
authors.forename: J
authors.initials: J
authors.lastname: Mayo
authors.forename: M
authors.initials: M
authors.lastname: García
authors.forename: B
authors.initials: B
authors.lastname: Ruiz
authors.forename: C
authors.initials: C
authors.lastname: Aguirre
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008297:Male; D008875:Middle Aged; D014391:Tuberculosis, Miliary / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab